We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Paramedics Can Safely Treat Patient Seizures in Ambulance

By HospiMedica staff writers
Posted on 10 Sep 2001
A study has found that patient seizures can be safely and effectively treated by paramedics using benzodiazepine drugs en route to the hospital, rather than waiting for hospital staff to administer the drugs. More...
Conducted by researchers at the University of California, San Francisco (UCSF, USA), the study was published in the August 30, 2001, issue of The New England Journal of Medicine (NEJM).

Quick treatment to stop potentially life-threatening seizures, preferably within 30 minutes of onset, can reduce the likelihood of brain damage. Although some paramedics already administer benzodiazepines, their practice is based on anecdotal evidence, not formal studies, say the researchers. This study is the first to systematically examine the benefits of early drug administration and determine if they outweigh potential serious side effects. Benzodiazepines can cause some people to stop breathing, to breathe too shallowly, and to suffer cardiac complications.

The study involved 205 patients diagnosed with "status epilepticus,” continuous or repeated seizures lasting at least five minutes without recovery of consciousness. About half had seizures as a result of epilepsy and the rest had seizures from causes such as alcohol abuse, adverse drug reactions, stroke, or trauma. Those who had received anti-seizure drugs in the ambulance were far more likely to be free of seizures by the time they reached the hospital than those who remained unmedicated en route. Almost 60% of those given lorazepam were free of seizures upon arrival, while 43% of those given
diazepam were free of seizures, suggesting that lorazepam was more effective. In contrast, only 21% of the unmedicated group were seizure-free on arrival.

"This study will reassure many emergency medical systems (EMS) that treatment with benzodizepines is both safe and effective,” said Brian Alldredge, PharmD, UCSF professor of clinical pharmacy and lead author. "It suggests too that lorazepam is likely to be a better choice than diazepam.”




Related Links:
Univ. of California, San Francisco

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.